ESElly Juliana Suoth

Elly Juliana Suoth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elly Juliana Suoth has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pemberdayaan Kelompok Tani Kekelor dan Pinangimbalian Desa Pinapalangkow Dalam Program Pelatihan Pembuatan Sabun Dari Daun Cengkeh

    by Elly Suoth, Karlah Lifie Mansauda, Julianri Sari Lebang

    Kelompok tani Kekelor dan Pinangimbalian di Desa Pinapalangkow merupakan kelompok tani yang tidak terlalu aktif, dimana kelompok tani ini hanya aktif pada masa panen saja. Hal ini terjadi karena para petani hanya fokus pada buah cengkehnya saja. Padahal ada bagian lain dari pohon cengkeh yang dapat dimanfaatkan seperti daun cengkeh. Daun cengkeh yang juga hampir sama dengan buah cengkeh memiliki metabolit sekunder yang dapat bermanfaat bagi tubuh manusia dapat di oleh untuk mendapatkan minyak cengkeh ataupun dapat di manfaatkan untuk pembuatan berbagai produk kesehatan lainnya. Untuk itu pendampingan atau pelatihan pembuatan sabun dari daun cengkeh ini sangat penting bagi kelompok tani Kekelor dan Pinangimbalian untuk dapat meningkatkan aktivitas dan penghasilan dari anggota kelompok tani. Selain upaya meningkatkan penghasilan bagi kedua kelompok tani yang ada di Desa Pinapalangkow, pelatihan pembuatan sabun mandi dengan bahan aktif daun cengkeh juga akan dapat memanfaatkan daun cengkeh yang banyak berjatuhan di setiap kebun dari para petani. Pelatihan pembuatan sabun mandi dari bahan aktif daun cengkeh ini juga sangat diharapkan dapat meningkatkan ekonomi dari para anggota kelompok

  • Open Access

    Network Pharmacology Approach to Understanding the Antidiabetic Effects of Pineapple Peel Hexane Extract

    by Christa Hana Angle Pendong, Elly Juliana Suoth, Fatimawali Fatimawali, Trina Ekawati Tallei

    The increased interest in exploring alternative treatments for type 2 diabetes mellitus is accompanied by a rise in the prevalence of type 2 diabetes mellitus. Pineapple peel is one of the by-products of pineapple fruit and is known to possess potential for anti-diabetic activity. In this study, the n-hexane extract of pineapple peel was analyzed using network pharmacology methods to ascertain its potential in treating type 2 diabetes mellitus. The GC-MS analysis of the n-hexane extract of pineapple peel revealed the presence of 42 compounds, with 8 of them considered safe as they met the Lipinski Rule of Five criteria for drug-likeness and were classified as safe with toxicity levels in classes IV and V. The pineapple peel extract targeted 55 proteins related to type 2 diabetes mellitus (DMT2), potentially affecting DMT2 through the AGE-RAGE pathway in diabetes complications and insulin resistance. Network pharmacology analysis identified five genes targeted by pineapple peel, namely MAPK1, JAK2, MAPK8, PRKCD, and PPARA. Among these genes, MAPK1 exhibited a higher overall score than the others. Apart from its role in diabetes, MAPK1 is also implicated in cancer.


  • Open Access

    In Vitro Antioxidant Activity of Chrysanthemum indicum Flowers Extract and Its Fraction

    by Jeclin Inebel Dolongtelide, Fatimawali Fatimawali, Trina Ekawati Tallei, Elly Juliana Suoth, Herny Emma Inonta Simbala, Irma Antasionasti, Marko Jeremia Kalalo

    Chrysanthemum indicum L., commonly known as Chrysanthemum flower, is an herbaceous plant that has a long-established history of medicinal usage. There has been extensive research about C. indicium L, especially about its antioxidant activities, but not much has been done on its fraction. This study aimed to explore the efficacy of the ethanol extract and its fraction derived from Chrysanthemum flowers in scavenging free radicals. The antioxidant potential of the ethanol extract, as well as its aqueous and n-hexane fractions, was evaluated using the 2,2-diphenyl-1-picrilhidrazine (DPPH) method in vitro. The degree of antioxidant activity was quantified by determining the IC50 value, which corresponds to the concentration of the extract or fractions required to inhibit 50% of DPPH free radicals. The results obtained from this investigation provide strong evidence that the ethanolic extract, as well as its aqueous and n-hexane fractions, exhibited significant antioxidant activity. The measured IC50 values for the ethanolic extract, aqueous fraction, and n-hexane fraction were 1.350 µg/mL, 1.109 µg/mL, and 7.588 µg/mL, respectively.


  • Open Access

    Molecular docking of bioactive compounds of nut grass (Cyperus rotundus L.) tuber against SARS-CoV-2

    by Adinda Dwi Tania, Elly Suoth, Fatimawali, Siti Marfuah, Ahmad Akroman Adam, Rinaldi Idroes, Trina Ekawati Tallei

    Coronavirus Disease-2019 (COVID-19) is a novel coronavirus infection that causes severe acute respiratory syndrome 2 (SARS-CoV-2). Compounds with therapeutic potential for this disease are still being investigated, ranging from approved medications to natural compounds. Nut grass (Cyperus rotundus L.) is a plant that has been reported to have antiviral activities against several types of viruses, however, there have been no reported studies on its tuber antiviral activity against SARS-CoV-2. The purpose of this study was to evaluate the potential antiviral activity of nut grass tubers by applying an in silico approach against the SARS-CoV-2 main protease (Mpro) and spike (S) glycoproteins. Methanol and n-hexane were used to extract the bioactive compounds, which were then analyzed using Gas Chromatography-Mass Spectrometry (GC-MS). The analysis resulted in the identification of 177 probable compounds in methanolic extract and 144 compounds in n-hexane extract. These compounds’ anti-SARS-CoV-2 activity was determined using molecular docking with B-d-N4-hydroxycytidine (NHC) (a metabolic product of molnupiravir) as a control ligand. Furthermore, the bioactivity of these compounds was assessed using SwissADME, admetSAR, and PASS Online. This study showed that 7-Hydroxy-6,9a-dimethyl-3-methylene-decahydro-azuleno[4,5-b]furan-2,9-dione (from methanolic extract); Androstan-17-one,3-ethyl-3-hydroxy,(5a)-(from methanolic extract); 2-[4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl]cyclohex-1-en-1-carboxaldehyde (from methanolic and n-hexane extracts); 2-Vinyl-9-[3-deoxy-ß-d-ribofuranosyl]hypoxanthine (from methanolic extract); and Pregan-20-one, 2-hydroxy-5,6-epoxy-15-methyl-(from methanolic and n-hexane extracts) have best binding affinity and interacted with important amino acid residues at the Mpro and S glycoprotein receptors. The findings of this study indicate that these compounds have the potential to be studied further as antiviral against SARS-CoV-2.


  • Open Access

    Designing an Epitope-Based Peptide Vaccine Derived from RNA-Dependent RNA Polymerase (RdRp) against Dengue Virus Serotype 2

    by Irma F. Wahongan, Elly J. Suoth, Fatimawali, Saad Alhumaid, Hawra Albayat, Mohammed Aljeldah, Basim R. Al Shammari, Mutaib M. Mashraqi, Ahmad A. Alshehri, Tarek Sulaiman, et al.

    Dengue fever (DF) continues to be one of the tropical and subtropical health concerns. Its prevalence tends to increase in some places in these regions. This disease is caused by the dengue virus (DENV), which is transmitted through the mosquitoes Aedes aegypti and A. albopictus. The treatment of DF to date is only supportive and there is no definitive vaccine to prevent this disease. The non-structural DENV protein, RNA-dependent RNA Polymerase (RdRp), is involved in viral replication. The RdRp-derived peptides can be used in the construction of a universal dengue vaccine. These peptides can be utilized as epitopes to induce immunity. This study was an in silico evaluation of the affinity of the potential epitope for the universal dengue vaccine to dendritic cells and the bonds between the epitope and the dendritic cell receptor. The peptide sequence MGKREKKLGEFGKAKG generated from dengue virus subtype 2 (DENV-2) RdRp was antigenic, did not produce allergies, was non-toxic, and had no homology with the human genome. The potential epitope-based vaccine MGKREKKLGEFGKAKG binds stably to dendritic cell receptors with a binding free energy of −474,4 kcal/mol. This epitope is anticipated to induce an immunological response and has the potential to serve as a universal dengue virus vaccine candidate.